Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice

BACKGROUND: Highly pathogenic avian H5N1 influenza virus is a major public health concern. Given the lack of effective vaccine and recent evidence of antiviral drug resistance in some isolates, alternative strategies for containment of a possible future pandemic are needed. Humanized monoclonal anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanson, Brendon J, Boon, Adrianus CM, Lim, Angeline PC, Webb, Ashley, Ooi, Eng Eong, Webby, Richard J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1626464/
https://www.ncbi.nlm.nih.gov/pubmed/17040574
http://dx.doi.org/10.1186/1465-9921-7-126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1626464/
https://www.ncbi.nlm.nih.gov/pubmed/17040574
http://dx.doi.org/10.1186/1465-9921-7-126

Ejemplares similares